SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Can the nucleic acid amplification test (NAT) be an alternative to the serologic tests? A prospective study, the results of 18,200 blood donors from the Turkish Red Crescent
4 references·2 citing·26 second hop
Can the nucleic acid amplification test (NAT) be an alternative to the serologic tests? A prospective study, the results of 18,200 blood donors from the Turkish Red Crescent (2010)Can the nucleic acid amplification test (…Transfusion transmitted diseases (2001)Transfusion transmitted disea…Nucleic acid amplification testing of blood donors fortransfusion‐transmitted infectious diseases (2000)Nucleic acid amplification te…False‐negative testing errors in routine viral marker screening of blood donors (2000)False‐negative testing errors…Current viral risks of blood and blood products (2000)Current viral risks of blood …Effectiveness of Using Nucleic Acid Amplification Test to Screen Blood Donors for Hepatitis B, Hepatitis C, and HIV: A Tertiary Care Hospital Experience From Pakistan (2023)Effectiveness of Using Nuclei…Trends in hepatitis B and hepatitis C virus seropositivity among blood donors over 15years screened in the blood bank of a university hospital (2012)Trends in hepatitis B and hep…The Risk of Transfusion-Transmitted Viral Infections (1996)Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting (1999)NAT of the United States and Canadian blood supply (2000)Cost‐effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States (2004)Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors. (2008)HBV, HCV and HIV seroprevalence among blood donors in Istanbul, Turkey: how effective are the changes in the national blood transfusion policies? (2010)Positivity of HIV, hepatitis B and hepatitis C in patients enrolled in a confidential self-exclusion system of blood donation: a cross-sectional analytical study (2010)Seroprevalence and Trends in Transfusion Transmitted Infections Among Blood Donors in a University Hospital Blood Bank: A 5 Year Study (2010)Transmission of Human Immunodeficiency Virus (HIV) by Blood Transfusions Screened as Negative for HIV Antibody (1988)Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States (1995)[Risk of transfusional-transmitted infections]. (2002)Reduced frequency of blood donors with false‐positive HIV‐1 and ‐2 antibody EIA reactivity after elution of low‐affinity nonspecific natural antibodies (2002)Impact of changes in viral marker screening assays (2003)Manson's Tropical Diseases. (1973)The United States General Accounting Office (2004)Study of Blood-transfusion Services in Maharashtra and Gujarat States, India (2009)Decreasing Prevalence of Transfusion Transmitted Infection in Indian Scenario (2014)Blood Transfusion-Associated Infections in the Twenty-First Century: New Challenges (2020)The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection (1997)False-Positive HIV-1 Test Results in a Low-Risk Screening Setting of Voluntary Blood Donation (1998)HIV, HBV and HCV: New Developments Related to Transfusion Safety (2000)Does prevalence of transfusion‐transmissible viral infection reflect corresponding incidence in United States blood donors? (2005)The evolving blood donor deferral policy for men who have sex with men: impact on the risk of HIV transmission by transfusion in France (2020)A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6‐year survey (2008)Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms (2010)
this work references cited by second hop

References

  • 2000Nucleic acid amplification testing of blood donors fortransfusion‐transmitted infectious diseases218 cited
  • 2000Current viral risks of blood and blood products64 cited
  • 2001Transfusion transmitted diseases57 cited
  • 2000False‐negative testing errors in routine viral marker screening of blood donors48 cited

Cited by

  • 2012Trends in hepatitis B and hepatitis C virus seropositivity among blood donors over 15years screened in the blood bank of a university hospital10 cited
  • 2023Effectiveness of Using Nucleic Acid Amplification Test to Screen Blood Donors for Hepatitis B, Hepatitis C, and HIV: A Tertiary Care Hospital Experience From Pakistan6 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work